Le Registre des lobbyistes
Version 15 de 17 (2006-09-14 à 2007-04-13) a été soumis avant l'entrée en vigueur de la Loi sur le lobbying, le 2 juillet 2008. En raison d'exigences de renseignements différents à ce moment-là, l'enregistrement est présenté sous le format suivant.
| Organisation : |
Association canadienne des soins de santé / Canadian Healthcare Association
17 YORK STREET OTTAWA, ON K1N 9J6 Canada |
||||
| Numéro de téléphone : | 613-241-8005 | ||||
| Numéro de fax : | 613-241-5055 | ||||
| Nom et poste de l'agent responsable pendant la période de cet enregistrement : | SHARON SHOLZBERG-GRAY, PRESIDENT AND CEO | ||||
| Description des activités de l'organisation : | CHA is a leader in developing, and advocating for, health policy solutions that meet the needs of Canadians. CHA's distance learning programs, conferences and publishing services contribute to this national leadership. CHA and its members are committed to a publicly-funded health system that provides access to a continuum of comparable health services throughout Canada. | ||||
| Membres ou types de membres de l'organisation. : | CHA's members are Canada's provincial and territorial hospital and health organizations representing a broad continuum of care including acute care, home and community care, long term care, public health, mental health, palliative care, addiction services, children, youth and family services and housing services. | ||||
| L'organisation a-t-elle été financée en tout ou en partie par une institution gouvernementale domestique ou étrangère au cours du dernier exercice financier complet? | Oui | ||||
| Date de la fin du dernier exercice financier complet de l'organisation : | 2005-12-31 | ||||
|
|||||
| Nom : | Garnet Burns |
| Titre du poste : | Board Chair |
| Charges publiques occupées : | Non |
| Nom : | Lynda Cranston |
| Titre du poste : | Board Chair Elect |
| Charges publiques occupées : | Non |
| Nom : | DENISE DESAUTELS |
| Titre du poste : | DIRECTOR, POLICY AND COMMUNICATIONS |
| Charges publiques occupées : | Oui |
| Nom : | DELLA FAULKNER |
| Titre du poste : | SENIOR HEALTH POLICY ANALYST |
| Charges publiques occupées : | Non |
| Nom : | SHARON SHOLZBERG-GRAY |
| Titre du poste : | PRESIDENT AND CEO |
| Charges publiques occupées : | Oui |
| Nom : | Graeme Wilkes |
| Titre du poste : | Communications Advisor |
| Charges publiques occupées : | Oui |
| Institutions fédérales qui ont été ou seront consultées au cours de l'engagement. : | Affaires autochtones et Développement du Nord Canada, Agence de la santé publique du Canada (ASPC), Anciens Combattants Canada (ACC), Bureau du Conseil privé (BCP), Cabinet du Premier ministre (CPM), Canadian Institute for Health Information, Canadian Patient Safety Institute, Citoyenneté et Immigration Canada, Conseil d'examen du prix des médicaments brevetés (CEPMB), Députés de la Chambre des communes, Développement des ressources humaines Canada (DRHC), Finances Canada (FIN), Health Council of Canada, House of Commons Standing Committee on Finance, House of Commons Standing Committee on Health, Industrie Canada, Instituts de recherche en santé du Canada (IRSC), Ministry of Intergovernmental Affairs, Office of the Auditor General, Revenu Canada (RC), Santé Canada (SC), Senate Standing Committee on Social Affairs, Science and Technology, Statistique Canada (StatCan) | ||||||
|
Techniques de communication déjà utilisées ou qui seront utilisées au cours de l'engagement :
|
Appel au grand public, Appels téléphoniques, Communications informelles, Communications écrites, en format papier ou électronique, Présentations, Réunions | ||||||
| Objet : Sujets de préoccupation : | Affaires autochtones, Commerce intérieur, Commerce international, Éducation, Emploi et formation, Environnement, Immigration, Impôts et finances, Industrie, Questions constitutionnelles, Questions touchant les consommateurs, Santé, Sciences et technologies, Travail | ||||||
| Objets poursuivis : Renseignements rétrospectifs : | 1) Health system employability issues, including the need for a national health human resources strategy or mechanism2) Pre-budget and budget consultations3) Pharmaceutical issues, including the elements of a proposed national pharmaceuticals strategy (Catastrophic Pharmaceutical Coverage, National Drug Formulary, Drug Approval Process, Evaluation of Real-World Drug Safety and Effectiveness, Purchasing Strategies, Optimal and Appropriate Use of Pharmaceuticals, Electronic Health Records and E-Prescribing, Access and Cost of Generic Drugs, Improving Cost-Effectiveness Analysis of Drugs) 4) Postsecondary education and training as they relate to the health system5) The 'fiscal imbalance' between the federal government and the provinces and territories6) Current challenges and future directions of the Canadian health system7) Health Canada's Blueprint for Renewal, including the Progressive Licensing Framework.8) Federal funding for the health system, including the Canada Health Transfer and the Equalization program9) Public-private issues, including the appropriate mix of public and private funding and delivery of health services in the Canadian health system10) Public health issues, including emergency preparedness, pandemic planning, health promotion and the management of chronic diseases11) Health system effectiveness, including issues of governance and accountability12) The federal role in Canada's health system, including the use of the federal spending power and national objectives13) The continuum of care, including the need for a mental health commission and expanded home- and continuing-care supports.14) Health system information technology, including an electronic health record15) Timely access to health services, including wait times, benchmarks and wait times guarantees16) The determinants of health, including investments in postsecondary education and the environment.17) Health research18) Taxation issues, including the GST rebate for medical services19) Patient safety and quality improvement20) Primary health care | ||||||
| Objets poursuivis : Renseignements prospectifs : | 1) Health human resources2) The federal budget3) Pharmaceutical issues, including the elements of a proposed national pharmaceuticals strategy (Catastrophic Pharmaceutical Coverage, National Drug Formulary, Drug Approval Process, Evaluation of Real-World Drug Safety and Effectiveness, Purchasing Strategies, Optimal and Appropriate Use of Pharmaceuticals, Electronic Health Records and E-Prescribing, Access and Cost of Generic Drugs, Improving Cost-Effectiveness Analysis of Drugs)4) Federal-provincial-territorial fiscal relations, including the Canada Health Transfer, Canada Social Transfer and Equalization program5) Public-private issues, including the appropriate mix of public and private funding and delivery of health services in the Canadian health system 6) Public health issues, including emergency preparedness, pandemic planning, health promotion and the management of chronic diseases7) Health system effectiveness, including issues of governance and accountability8) The federal role in Canada's health system, including the use of the federal spending power and national objectives9) The continuum of care, including the need for a mental health commission and expanded home- and continuing-care supports.10) Health system information technology, including an electronic health record11) Timely access to health services, including wait times, benchmarks and wait times guarantees12) The determinants of health, including investments in postsecondary education and the environment.13) Health research14) Taxation issues, including the GST rebate for medical services15) Patient safety and improvement16) Primary health care17) Aboriginal health | ||||||
Détails sur l'objet indiqué
|
|||||||